GlassScriptPhysician profile
Arpine Barsegian
NPI 1780070649
$11,066.15
in general payments reported to CMS, 2019-2025
26 companies · $2,026 in 2025
The $2,026 reported for 2025 was more than what 88% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $495 · 2020: $126 · 2021: $537 · 2022: $752 · 2023: $4,715 · 2024: $2,416 · 2025: $2,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,325 · Food and Beverage: $2,831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,325.00 |
| Food and Beverage | $2,831.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $7,039.16 | 2019-2025 | Hydrus Microstent, Rocklatan, Rhopressa |
| Sun Pharmaceutical Industries INC. | $493.74 | 2021-2025 | Cequa |
| Amgen INC. | $376.81 | 2024-2025 | Tepezza |
| Bausch & Lomb Americas INC. | $276.37 | 2022-2025 | Vyzulta, Miebo, Xiidra |
| Sight Sciences, INC. | $243.70 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Allergan, INC. | $229.61 | 2021-2022 | |
| Abbvie INC. | $219.84 | 2022-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $216.58 | 2019-2025 | Tecnis Simplicity |
| New World Medical,INC. | $212.73 | 2025 | Clearpath, Via360, Streamline |
| Tarsus Pharmaceuticals, INC. | $199.19 | 2025 | Xdemvy |
| Glaukos Corporation | $188.77 | 2024-2025 | Idosetr, Istent Trabecular Micro-Bypass System Model Is3 |
| Oyster Point Pharma, INC. | $174.12 | 2022-2025 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $170.68 | 2019-2023 | |
| Aerie Pharmaceuticals, INC. | $165.30 | 2021 | |
| Genentech USA, INC. | $149.04 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $131.47 | 2019 | |
| Kala Pharmaceuticals, INC. | $125.89 | 2020 | |
| Glaxosmithkline, LLC. | $125.00 | 2022 | |
| Eyepoint US, INC. | $124.92 | 2019 | |
| Biotissue Holdings INC. | $47.30 | 2024 | |
| Thea Pharma INC. | $39.07 | 2022-2024 | Iyuzeh |
| Harrow Eye, LLC | $34.86 | 2025 | Vevye |
| Horizon Therapeutics Plc | $23.42 | 2022 | |
| Ani Pharmaceuticals, INC. | $22.52 | 2025 | Purified Cortrophin Gel |
| Dompe US, INC. | $20.08 | 2023 | Oxervate |
| Rxsight INC | $15.98 | 2024 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arpine Barsegian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.